ARCHIVES

Senate Confirms McClellan For FDA

This article is from The Cancer Letter archive.

Vol. 28 No. 39 | October 25, 2002

Download PDF Visit The Full Archive

Related Articles

“Treatment INDs” Seen As Major Threat To Clinical Trials

August 21, 1987

Advocates Call For Metrics And Action Plan In NCI’s Redesign of Cooperative Groups

July 8, 2011

Army Hopes To Fund “Middle-Risk, high Payoff” Research With Breast Cancer money. Travis Says

February 19, 1993

mTOR Inhibitor Improves PFS In Metastatic Sarcoma Patients

February 25, 2011

Has The Pendulum Swing too Far Toward Grants? NCI, NCAB Ponder Best Way to Stimulate Work In New areas

December 5, 1980

NCI Backed Studies Indicate Overweight Not Much Of a Cancer Risk Factor

June 19, 1987